Incyte Stock Price - INCY


-79.30 (-100.00%)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Incyte Corporation INCY NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 79.30 0.00 0.00 0.00 79.30 04:50:40
Bid Price Ask Price Spread Spread % News
77.64 81.21 3.57 4.4% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.00 USD

Incyte Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 17.08B 215.40M $ 109.49M 0.51 42.00 212.52M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Incyte News

Loading Messages....

Latest INCY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical INCY Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week76.4079.3375.0177.651,674,1002.903.8%
1 Month78.8380.6071.8475.981,269,1030.470.6%
3 Months94.4196.7971.8483.051,455,714-15.11-16.0%
6 Months84.0896.7971.8482.011,229,206-4.78-5.69%
1 Year84.2596.7971.8481.921,212,732-4.95-5.88%
3 Years121.09153.1557.0091.851,633,855-41.79-34.51%
5 Years78.61153.1555.0092.761,523,1840.690.88%

Incyte Description

Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant, which Eli Lilly licenses, and oncology drug Iclusig for chronic myeloid leukemia. Incyte's pipeline includes a broad array of oncology and autoimmune programs.


Your Recent History
NASDAQ
INCY
Incyte
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.